O'Rourke & Company’s Oracle ORCL Stock Holding History

O'Rourke & Company’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-971	Closed	-$273K	–	170
2025 Q3	$273K	Hold	971	–	–	0.11%	142
2025 Q2	$212K	Buy	+971	New	+$157K	0.1%	148

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

O'Rourke & Company's ORCL Position: Q4 2025 in Review

O'Rourke & Company sold out of Oracle (ORCL) in Q4 2025, closing a stake of 971 shares — an estimated $273K sold.

O'Rourke & Company first reported a position in ORCL in Q2 2025 and held it in 2 quarters. The position peaked at $273K in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

O'Rourke & Company reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
O'Rourke & Company sold 971 Oracle shares in Q4 2025, an estimated $273K.
O'Rourke & Company first reported a position in Oracle in Q2 2025 and held it in 2 quarters.
O'Rourke & Company's Oracle position peaked at $273K in Q3 2025.
3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on O'Rourke & Company's 13F filing for Q4 2025, filed 28 Jan 2026.